Literature DB >> 15606800

Influence of pathological progression on the balance between cellular and humoral immune responses in bovine tuberculosis.

Michael D Welsh1, Rodat T Cunningham, David M Corbett, R Martyn Girvin, James McNair, Robin A Skuce, David G Bryson, John M Pollock.   

Abstract

Studies of tuberculosis have suggested a shift in dominance from a T helper type 1 (Th1) towards a Th2 immune response that is associated with suppressed cell-mediated immune (CMI) responses and increased humoral responses as the disease progresses. In this study a natural host disease model was used to investigate the balance of the evolving immune response towards Mycobacterium bovis infection in cattle with respect to pathogenesis. Cytokine analysis of CD4 T-cell clones derived from M. bovis-infected animals gave some indication that there was a possible relationship between enhanced pathogenesis and an increased ratio of Th0 [interleukin-4-positive/interferon-gamma-positive (IL-4(+)/IFN-gamma(+))] clones to Th1 (IFN-gamma(+)) clones. All animals developed strong antimycobacterial CMI responses, but depressed cellular responses were evident as the disease progressed, with the IFN-gamma test failing to give consistently positive results in the latter stages. Furthermore, a stronger Th0 immune bias, depressed in vitro CMI responses, elevated levels of IL-10 expression and enhanced humoral responses were also associated with increased pathology. In minimal disease, however, a strong Th1 immune bias was maintained and an anti-M. bovis humoral response failed to develop. It was also seen that the level of the anti-M. bovis immunoglobulin G1 (IgG1) isotype antibody responses correlated with the pathology scores, whereas CMI responses did not have as strong a relationship with the development of pathology. Therefore, the development and maintenance of a Th1 IFN-gamma response is associated with a greater control of M. bovis infection. Animals progressing from a Th1-biased to a Th0-biased immune response developed more extensive pathology and performed less well in CMI-based diagnostic tests but developed strong IgG1 humoral responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15606800      PMCID: PMC1782060          DOI: 10.1111/j.1365-2567.2004.02003.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

1.  Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement.

Authors:  D Dlugovitzky; A Torres-Morales; L Rateni; M A Farroni; C Largacha; O Molteni; O Bottasso
Journal:  FEMS Immunol Med Microbiol       Date:  1997-07

2.  Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle.

Authors:  J M Pollock; D A Pollock; D G Campbell; R M Girvin; A D Crockard; S D Neill; D P Mackie
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 3.  The role of T-cell subsets in Mycobacterium tuberculosis infection.

Authors:  W H Boom
Journal:  Infect Agents Dis       Date:  1996-03

4.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.

Authors:  V A Boussiotis; E Y Tsai; E J Yunis; S Thim; J C Delgado; C C Dascher; A Berezovskaya; D Rousset; J M Reynes; A E Goldfeld
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

5.  In vitro responsiveness of gammadelta T cells from Mycobacterium bovis-infected cattle to mycobacterial antigens: predominant involvement of WC1(+) cells.

Authors:  A J Smyth; M D Welsh; R M Girvin; J M Pollock
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  IgG isotype antibody responses to epitopes of the Mycobacterium bovis protein MPB70 in immunised and in tuberculin skin test-reactor cattle.

Authors:  K A Lightbody; J McNair; S D Neill; J M Pollock
Journal:  Vet Microbiol       Date:  2000-07-31       Impact factor: 3.293

7.  Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis.

Authors:  S G Rhodes; N Palmer; S P Graham; A E Bianco; R G Hewinson; H M Vordermeier
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

8.  Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB).

Authors:  D Dlugovitzky; M L Bay; L Rateni; G Fiorenza; L Vietti; M A Farroni; O A Bottasso
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

9.  Immunochemical characterization of the MPB70/80 and MPB83 proteins of Mycobacterium bovis.

Authors:  H G Wiker; K P Lyashchenko; A M Aksoy; K A Lightbody; J M Pollock; S V Komissarenko; S O Bobrovnik; I N Kolesnikova; L O Mykhalsky; M L Gennaro; M Harboe
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

10.  Absence of a prominent Th2 cytokine response in human tuberculosis.

Authors:  Y Lin; M Zhang; F M Hofman; J Gong; P F Barnes
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

View more
  49 in total

1.  Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette-Guérin vaccination.

Authors:  S Widdison; L J Schreuder; B Villarreal-Ramos; C J Howard; M Watson; T J Coffey
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Lymphocyte functions in dairy cows in hot environment.

Authors:  Nicola Lacetera; Umberto Bernabucci; Daniela Scalia; Bruno Ronchi; Giorgina Kuzminsky; Alessandro Nardone
Journal:  Int J Biometeorol       Date:  2005-07-01       Impact factor: 3.787

3.  Development and evaluation of a test for tuberculosis in live European badgers (Meles meles) based on measurement of gamma interferon mRNA by real-time PCR.

Authors:  J Sawyer; D Mealing; D Dalley; D Davé; S Lesellier; S Palmer; J Bowen-Davies; T R Crawshaw; M A Chambers
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

4.  Serological Analysis of Tuberculosis in Goats by Use of the Enferplex Caprine TB Multiplex Test.

Authors:  Amanda O'Brien; Clare Whelan; John B Clarke; Alastair Hayton; Neil J Watt; Gordon D Harkiss
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

5.  Enemies and turncoats: bovine tuberculosis exposes pathogenic potential of Rift Valley fever virus in a common host, African buffalo (Syncerus caffer).

Authors:  B R Beechler; C A Manore; B Reininghaus; D O'Neal; E E Gorsich; V O Ezenwa; A E Jolles
Journal:  Proc Biol Sci       Date:  2015-04-22       Impact factor: 5.349

6.  Experimental Fasciola hepatica infection alters responses to tests used for diagnosis of bovine tuberculosis.

Authors:  Robin J Flynn; Celine Mannion; Olwen Golden; Orcun Hacariz; Grace Mulcahy
Journal:  Infect Immun       Date:  2006-12-28       Impact factor: 3.441

7.  Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.

Authors:  Sarah L Young; Lynn Slobbe; Rachel Wilson; Bryce M Buddle; Geofferey W de Lisle; Glenn S Buchan
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

8.  T-cell mRNA expression in response to Mycobacterium bovis BCG vaccination and Mycobacterium bovis infection of white-tailed deer.

Authors:  Tyler C Thacker; Mitchell V Palmer; W Ray Waters
Journal:  Clin Vaccine Immunol       Date:  2009-06-10

9.  Repeat tuberculin skin testing leads to desensitisation in naturally infected tuberculous cattle which is associated with elevated interleukin-10 and decreased interleukin-1 beta responses.

Authors:  Michael Coad; Derek Clifford; Shelley G Rhodes; R Glyn Hewinson; H Martin Vordermeier; Adam O Whelan
Journal:  Vet Res       Date:  2009-10-20       Impact factor: 3.683

10.  Bayesian receiver operating characteristic estimation of multiple tests for diagnosis of bovine tuberculosis in Chadian cattle.

Authors:  Borna Müller; Penelope Vounatsou; Bongo Naré Richard Ngandolo; Colette Diguimbaye-Djaïbe; Irene Schiller; Beatrice Marg-Haufe; Bruno Oesch; Esther Schelling; Jakob Zinsstag
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.